Fidelity Investments’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Fidelity Investments’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-21,000	Closed	-$291K	–	5628
2022 Q3	$291K	Hold	21,000	–	–	﹤0.01%	2941
2022 Q2	$845K	Sell	21,000 -22	-0.1%	-$1.36K	﹤0.01%	2720
2022 Q1	$2.21M	Buy	21,022 +22	+0.1%	+$1.61K	﹤0.01%	2580
2021 Q4	$2.42M	Hold	21,000	–	–	﹤0.01%	2523
2021 Q3	$7.95M	Hold	21,000	–	–	﹤0.01%	2207
2021 Q2	$8.57M	Hold	21,000	–	–	﹤0.01%	2168
2021 Q1	$10M	Buy	+21,000	New	+$11.4M	﹤0.01%	2035

Other funds holding NEXI

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Allen Operations New York $722M AUM 20.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

Fidelity Investments's NEXI Position: Q4 2022 in Review

Fidelity Investments sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2022, closing a stake of 21,000 shares — an estimated $291K sold.

Fidelity Investments first reported a position in NEXI in Q1 2021 and held it in 7 quarters. The position peaked at $10M in Q1 2021. 29 funds tracked by Wall St. Rank hold NEXI as of Q4 2022.

Fidelity Investments reported no remaining NexImmune, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Fidelity Investments sold 21,000 NexImmune, Inc. Common Stock shares in Q4 2022, an estimated $291K.
Fidelity Investments first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Fidelity Investments's NexImmune, Inc. Common Stock position peaked at $10M in Q1 2021.
29 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2022.

Based on Fidelity Investments's 13F filing for Q4 2022, filed 13 Feb 2023.